Abstract
It previously has been demonstrated that zidovudine (AZT) is lethal to early murine embryos. The effect of the drug on pre- and postimplantation embryos was examined to delineate the timing of this toxicity and to investigate its possible mechanisms. Embryos exposed in the whole mouse during preblastocyst development were unable to proceed beyond the blastocyst stage. Similarly, when two-cell embryos harvested from unexposed females were exposed to low-concentration (1 microM) AZT in vitro over 24 h, development beyond the blastocyst stage was inhibited. In contrast, drug exposure during in vitro blastocyst and postblastocyst development resulted in little or no morphologic toxicity. Further investigation revealed that preblastocyst AZT exposure resulted in the development of blastocysts with significantly lower cell numbers than control embryos. While embryonic exposure to AZT at the blastocyst and postblastocyst stages also resulted in retarded cell division, the effects were milder than those recorded after preblastocyst exposure. These data demonstrate that the critical period of AZT toxicity toward murine embryos is between ovulation and implantation and indicate that AZT directly suppresses cell division in the preimplantation embryo.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arnaudo E., Dalakas M., Shanske S., Moraes C. T., DiMauro S., Schon E. A. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet. 1991 Mar 2;337(8740):508–510. doi: 10.1016/0140-6736(91)91294-5. [DOI] [PubMed] [Google Scholar]
- Calarco P. G., Brown E. H. An ultrastructural and cytological study of preimplantation development of the mouse. J Exp Zool. 1969 Jul;171(3):253–283. doi: 10.1002/jez.1401710303. [DOI] [PubMed] [Google Scholar]
- Chen C. H., Cheng Y. C. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine. J Biol Chem. 1989 Jul 15;264(20):11934–11937. [PubMed] [Google Scholar]
- Chen C. H., Vazquez-Padua M., Cheng Y. C. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol. 1991 May;39(5):625–628. [PubMed] [Google Scholar]
- Dalakas M. C., Illa I., Pezeshkpour G. H., Laukaitis J. P., Cohen B., Griffin J. L. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med. 1990 Apr 19;322(16):1098–1105. doi: 10.1056/NEJM199004193221602. [DOI] [PubMed] [Google Scholar]
- Gogu S. R., Beckman B. S., Agrawal K. C. Amelioration of zidovudine-induced fetal toxicity in pregnant mice. Antimicrob Agents Chemother. 1992 Nov;36(11):2370–2374. doi: 10.1128/aac.36.11.2370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Magnuson T., Epstein C. J. Oligosyndactyly: a lethal mutation in the mouse that results in mitotic arrest very early in development. Cell. 1984 Oct;38(3):823–833. doi: 10.1016/0092-8674(84)90277-0. [DOI] [PubMed] [Google Scholar]
- Minkoff H. L., DeHovitz J. A. Care of women infected with the human immunodeficiency virus. JAMA. 1991 Oct 23;266(16):2253–2258. [PubMed] [Google Scholar]
- Panegyres P. K., Papadimitriou J. M., Hollingsworth P. N., Armstrong J. A., Kakulas B. A. Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment. J Neurol Neurosurg Psychiatry. 1990 Aug;53(8):649–655. doi: 10.1136/jnnp.53.8.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sharpe A. H., Hunter J. J., Ruprecht R. M., Jaenisch R. Maternal transmission of retroviral disease and strategies for preventing infection of the neonate. J Virol. 1989 Mar;63(3):1049–1053. doi: 10.1128/jvi.63.3.1049-1053.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sharpe A. H., Jaenisch R., Ruprecht R. M. Retroviruses and mouse embryos: a rapid model for neurovirulence and transplacental antiviral therapy. Science. 1987 Jun 26;236(4809):1671–1674. doi: 10.1126/science.3037694. [DOI] [PubMed] [Google Scholar]
- Simpson M. V., Chin C. D., Keilbaugh S. A., Lin T. S., Prusoff W. H. Studies on the inhibition of mitochondrial DNA replication by 3'-azido-3'-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication. Biochem Pharmacol. 1989 Apr 1;38(7):1033–1036. doi: 10.1016/0006-2952(89)90245-1. [DOI] [PubMed] [Google Scholar]
- Sperling R. S., Stratton P., O'Sullivan M. J., Boyer P., Watts D. H., Lambert J. S., Hammill H., Livingston E. G., Gloeb D. J., Minkoff H. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N Engl J Med. 1992 Mar 26;326(13):857–861. doi: 10.1056/NEJM199203263261303. [DOI] [PubMed] [Google Scholar]
- Stern S., Biggers J. D., Anderson E. Mitochondria and early development of the mouse. J Exp Zool. 1971 Feb;176(2):179–191. doi: 10.1002/jez.1401760206. [DOI] [PubMed] [Google Scholar]
- TARKOWSKI A. K. Experiments on the development of isolated blastomers of mouse eggs. Nature. 1959 Oct 24;184:1286–1287. doi: 10.1038/1841286a0. [DOI] [PubMed] [Google Scholar]
- Tarkowski A. K., Wróblewska J. Development of blastomeres of mouse eggs isolated at the 4- and 8-cell stage. J Embryol Exp Morphol. 1967 Aug;18(1):155–180. [PubMed] [Google Scholar]
- Toltzis P., Marx C. M., Kleinman N., Levine E. M., Schmidt E. V. Zidovudine-associated embryonic toxicity in mice. J Infect Dis. 1991 Jun;163(6):1212–1218. doi: 10.1093/infdis/163.6.1212. [DOI] [PubMed] [Google Scholar]
- Yarchoan R., Mitsuya H., Myers C. E., Broder S. Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides. N Engl J Med. 1989 Sep 14;321(11):726–738. doi: 10.1056/NEJM198909143211106. [DOI] [PubMed] [Google Scholar]
